Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
Published online before print March 1, 2006, doi:10.1212/01.wnl.0000204294.28189.03)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
01.wnl.0000204294.28189.03v1
66/6/919    most recent
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schifitto, G.
Right arrow Articles by Gelbard, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schifitto, G.
Right arrow Articles by Gelbard, H.
Related Collections
Right arrow HIV
Right arrow All Clinical trials
Right arrow Clinical trials Observational study (Cohort, Case control)
Right arrow HIV dementia
Right arrow Antiepileptic drugs
NEUROLOGY 2006;66:919-921
© 2006 American Academy of Neurology
Brief Communications

Valproic acid adjunctive therapy for HIV-associated cognitive impairment: A first report

G. Schifitto, MD, D. R. Peterson, PhD, J. Zhong, PhD, H. Ni, MS, K. Cruttenden, MS, RN, M. Gaugh, MA, H. E. Gendelman, MD, M. Boska, PhD and H. Gelbard, MD, PhD

From the Departments of Neurology (G.S., K.C., M.G., H.G.), Biostatistics (D.R.P.), and Radiology (J.Z., H.N.), University of Rochester Medical Center, Rochester, NY; and Departments of Pharmacology and Experimental Neuroscience (H.E.G.) and Radiology (M.B.), University of Nebraska Medical Center, Omaha.

Address correspondence and reprint requests to Dr. Giovanni Schifitto, Department of Neurology, Movement and Inherited Neurologic Disorders, Clinical Trials Coordination Center, 1351 Mount Hope Avenue, Suite 223, Rochester, NY 14620; e-mail: giovanni.schifitto{at}ctcc.rochester.edu

In vitro and animal model data demonstrate that valproic acid (VPA) can ameliorate HIV-associated neurotoxicity. The authors conducted a pilot 10-week placebo-controlled study of VPA 250 mg twice daily in 22 HIV-infected individuals with (n = 16) and without (n = 6) cognitive impairment. VPA was safe and well tolerated, with trends toward improved neuropsychological performance and brain metabolism in the impaired subjects.

Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the March 28 issue to find the title link for this article.

This article was previously published in electronic format as an Expedited E-Pub at www.neurology.org.

Supported by NIH grants P01 MH64570, U01 AI27658, and R01 MH64409 and General Clinical Research Center grant M01 RR00044 from the National Center for Research Resources, NIH.

Disclosure: The authors report no conflicts of interest.

Received August 10, 2005. Accepted in final form December 29, 2005.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
D. Eggert, P. K. Dash, S. Gorantla, H. Dou, G. Schifitto, S. B. Maggirwar, S. Dewhurst, L. Poluektova, H. A. Gelbard, and H. E. Gendelman
Neuroprotective Activities of CEP-1347 in Models of NeuroAIDS
J. Immunol., January 15, 2010; 184(2): 746 - 756.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
G. Schifitto, C. T. Yiannoutsos, T. Ernst, B. A. Navia, A. Nath, N. Sacktor, C. Anderson, C. M. Marra, D. B. Clifford, and For the ACTG 5114 Team
Selegiline and oxidative stress in HIV-associated cognitive impairment
Neurology, December 8, 2009; 73(23): 1975 - 1981.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
R. DiCenzo, D. R. Peterson, K. Cruttenden, P. Mariuz, N. L. Rezk, J. Hochreiter, H. Gelbard, and G. Schifitto
Effects of Minocycline and Valproic Acid Coadministration on Atazanavir Plasma Concentrations in Human Immunodeficiency Virus-Infected Adults Receiving Atazanavir-Ritonavir
Antimicrob. Agents Chemother., September 1, 2008; 52(9): 3035 - 3039.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
G. Schifitto, J. Zhang, S. R. Evans, N. Sacktor, D. Simpson, L. L. Millar, V. L. Hung, E. N. Miller, E. Smith, R. J. Ellis, et al.
A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment
Neurology, September 25, 2007; 69(13): 1314 - 1321.
[Abstract] [Full Text] [PDF]